Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection
Pompilia Radu(University of Bern), Olivia Keiser(University of Geneva), Jonas Schropp(University of Bern), Markus H. Heim(University of Basel), Francesco Negro(University Hospital of Geneva), Annalisa Berzigotti(University of Bern), Chiara Becchetti(Società Italiana di Reumatologia), Patrizia Künzler‐Heule(University of St.Gallen), Darius Moradpour(University Hospital of Lausanne), David Semela(Kantonsspital St. Gallen), Olivier Clerc(Hospital Neuchâtel), Patrick Schmid(University of St.Gallen), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), M. Roelens(BIOASTER), Beat Müllaupt(University Hospital Zurich)
Cited by 4
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral Therapy
|JNCI Journal of the National Cancer Institute|2005|857